Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism - An abscopal neuroprotective effect

Neuroscience

Volumn 274, Issue , 2014, Pages 93-101

  Johnstone, D M ^a   El Massri, N ^a   Moro, C ^b   Spana, S ^a   Wang, X S ^a   Torres, N ^b   Chabrol, C ^b   De Jaeger, X ^b   Reinhart, F ^b   Purushothuman, S ^a   Benabid, A L ^b   Stone, J ^a   Mitrofanis, J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CEA GRENOBLE   (France)

Author keywords

Mouse model; MPTP; Near infrared light; Neuroprotection; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLIAL FIBRILLARY ACIDIC PROTEIN; TYROSINE 3 MONOOXYGENASE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRON TRANSPORT; GLIA CELL; IMMUNOHISTOCHEMISTRY; INFRARED RADIATION; LOCOMOTION; MALE; MOUSE; NEAR INFRARED IMAGING SYSTEM; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PARKINSONISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUBSTANTIA NIGRA PARS COMPACTA; ANIMAL; ASTROCYTE; BAGG ALBINO MOUSE; CELL COUNT; DISEASE MODEL; METABOLISM; MICROGLIA; PARKINSONIAN DISORDERS; PHOTOTHERAPY;

ANIMALS; ASTROCYTES; CELL COUNT; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED BALB C; MICROGLIA; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; PARS COMPACTA; PHOTOTHERAPY; TYROSINE 3-MONOOXYGENASE;

EID: 84902084691     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.05.023     Document Type: Article

References (51)

1. Abe M., Fujisawa K., Suzuki H., Sugimoto T., Kanno T. Role of 830nm low reactive level laser on the growth of an implanted glioma in mice. Keio J Med 1993, 42:177-179.
2. Ashkan K., Wallace B.A., Mitrofanis J., Pollo C., Brard P.Y., Fagret D., Benabid A.L. SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease. Parkinsonism Relat Disord 2007, 13:266-275.
3. Bjorklund A., Rosenblad C., Winkler C., Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 1997, 4:186-200.
4. Bramhall R.J., Mahady K., Peach A.H. Spontaneous regression of metastatic melanoma - clinical evidence of the abscopal effect. Eur J Surg Oncol 2014, 40:34-41.
5. Braverman B., McCarthy R.J., Ivankovich A.D., Forde D.E., Overfield M., Bapna M.S. Effect of helium-neon and infrared laser irradiation on wound healing in rabbits. Lasers Surg Med 1989, 9:50-58.
6. Byrnes K.R., Waynant R.W., Ilev I.K., Wu X., Barna L., Smith K., Heckert R., Gerst H., Anders J.J. Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury. Lasers Surg Med 2005, 36:171-185.
7. Chao Y.X., He B.P., Tay S.S. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. J Neuroimmunol 2009, 216:39-50.
8. Chung H., Dai T., Sharma S.K., Huang Y.Y., Carroll J.D., Hamblin M.R. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng 2012, 40:516-533.
9. De Taboada L., Yu J., El-Amouri S., Gattoni-Celli S., Richieri S., McCarthy T., Streeter J., Kindy M.S. Transcranial laser therapy attenuates amyloid-beta peptide neuropathology in amyloid-beta protein precursor transgenic mice. J Alzheimers Dis 2011, 23:521-535.
10. Desmet K.D., Paz D.A., Corry J.J., Eells J.T., Wong-Riley M.T., Henry M.M., Buchmann E.V., Connelly M.P., Dovi J.V., Liang H.L., Henshel D.S., Yeager R.L., Millsap D.S., Lim J., Gould L.J., Das R., Jett M., Hodgson B.D., Margolis D., Whelan H.T. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg 2006, 24:121-128.
11. Eells J, DeSmet K, Kirk D, Wong-Riley M, Whelan H, Ver Hoeve J, Nork T, Stone J, Valter K (2008) Photobiomodulation for the treatment of retinal injury and retinal degenerative diseases. In: Proceeding of light-activated tissue regeneration and therapy conference, Vol. I (Waynant R, Tata D, eds), pp 39-51. New York: Springer.
12. Eells J.T., Henry M.M., Summerfelt P., Wong-Riley M.T., Buchmann E.V., Kane M., Whelan N.T., Whelan H.T. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci U S A 2003, 100:3439-3444.
13. Grillo S.L., Duggett N.A., Ennaceur A., Chazot P.L. Non-invasive infra-red therapy (1072nm) reduces beta-amyloid protein levels in the brain of an Alzheimer's disease mouse model, TASTPM. J Photochem Photobiol B 2013, 123:13-22.
14. Hopkins J.T., McLoda T.A., Seegmiller J.G., David Baxter G. Low-level laser therapy facilitates superficial wound healing in humans: a triple-blind, sham-controlled study. J Athl Train 2004, 39:223-229.
15. Huang Y.Y., Chen A.C., Carroll J.D., Hamblin M.R. Biphasic dose response in low level light therapy. Dose Response 2009, 7:358-383.
16. Huot P., Levesque M., Parent A. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Brain 2007, 130:222-232.
17. Ivandic B.T., Ivandic T. Low-level laser therapy improves vision in patients with age-related macular degeneration. Photomed Laser Surg 2008, 26:241-245.
18. Jackson-Lewis V., Jakowec M., Burke R.E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 1995, 4:257-269.
19. Jensen H.A., Loukogeorgakis S., Yannopoulos F., Rimpilainen E., Petzold A., Tuominen H., Lepola P., Macallister R.J., Deanfield J.E., Makela T., Alestalo K., Kiviluoma K., Anttila V., Tsang V., Juvonen T. Remote ischemic preconditioning protects the brain against injury after hypothermic circulatory arrest. Circulation 2011, 123:714-721.
20. Johnstone D.M., Coleman K., Moro C., Torres N., Eells J.T., Baker G.E., Ashkan K., Stone J., Benabid A.L., Mitrofanis J. The potential of light therapy in Parkinson's disease. ChronoPhysiol Ther 2014, 4:1-14.
21. Kaminski J.M., Shinohara E., Summers J.B., Niermann K.J., Morimoto A., Brousal J. The controversial abscopal effect. Cancer Treat Rev 2005, 31:159-172.
22. Kharbanda R.K., Nielsen T.T., Redington A.N. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009, 374:1557-1565.
23. Lampl Y., Zivin J.A., Fisher M., Lew R., Welin L., Dahlof B., Borenstein P., Andersson B., Perez J., Caparo C., Ilic S., Oron U. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke 2007, 38:1843-1849.
24. Lapchak P.A., Wei J., Zivin J.A. Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 2004, 35:1985-1988.
25. Ludgate C.M. Optimizing cancer treatments to induce an acute immune response: radiation Abscopal effects, PAMPs, and DAMPs. Clin Cancer Res 2012, 18:4522-4525.
26. Ma J., Shaw V.E., Mitrofanis J. Does melatonin help save dopaminergic cells in MPTP-treated mice?. Parkinsonism Relat Disord 2009, 15:307-314.
27. Moro C., Torres N., El Massri N., Ratel D., Johnstone D.M., Stone J., Mitrofanis J., Benabid A.L. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains. BMC Neurosci 2013, 14:40.
28. Muili K.A., Gopalakrishnan S., Meyer S.L., Eells J.T., Lyons J.A. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670nm light. PLoS One 2012, 7:e30655.
29. Oron A., Oron U., Chen J., Eilam A., Zhang C., Sadeh M., Lampl Y., Streeter J., DeTaboada L., Chopp M. Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 2006, 37:2620-2624.
30. Oron A., Oron U., Streeter J., de Taboada L., Alexandrovich A., Trembovler V., Shohami E. Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits. J Neurotrauma 2007, 24:651-656.
31. Park H.J., Lee P.H., Bang O.Y., Lee G., Ahn Y.H. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 2008, 107:141-151.
32. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosmann K., Morgenstern R., Kupsch A. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol 2004, 185:272-280.
33. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego.
34. Peoples C, Shaw VE, Stone J, Jeffery G, Baker GE, Mitrofanis J (2012a) Survival of dopaminergic amacrine cells after near-infrared light treatment in MPTP-treated mice. ISRN Neurol 2012:850150.
35. Peoples C, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J (2012b) Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease. Parkinsonism Relat Disord 18:469-476.
36. Purushothuman S., Nandasena C., Johnstone D.M., Stone J., Mitrofanis J. The impact of near-infrared light on dopaminergic cell survival in a transgenic mouse model of parkinsonism. Brain Res 2013, 1535:61-70.
37. Rojas J.C., Gonzalez-Lima F. Low-level light therapy of the eye and brain. Eye Brain 2011, 3:49-67.
38. Shaw V.E., Keay K.A., Ashkan K., Benabid A.L., Mitrofanis J. Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus. Parkinsonism Relat Disord 2010, 16:338-344.
39. Shaw VE, Peoples C, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J (2012) Patterns of cell activity in the subthalamic region associated with the neuroprotective action of near-infrared light treatment in MPTP-treated mice. Parkinsons Dis 2012:296875.
40. Shaw V.E., Spana S., Ashkan K., Benabid A.L., Stone J., Baker G.E., Mitrofanis J. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. J Comp Neurol 2010, 518:25-40.
41. Stone J, Johnstone D, Mitrofanis J (2013) The helmet experiment in Parkinson's disease: an observation of the mechanism of neuroprotection by near infra-red light. In: Proceedings of the 9th world association for laser therapy congress, pp 17-20.
42. Tatton W.G., Kwan M.M., Verrier M.C., Seniuk N.A., Theriault E. MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells. Brain Res 1990, 527:21-31.
43. Tuby H., Maltz L., Oron U. Modulations of VEGF and iNOS in the rat heart by low level laser therapy are associated with cardioprotection and enhanced angiogenesis. Lasers Surg Med 2006, 38:682-688.
44. Tuby H., Maltz L., Oron U. Low-level laser irradiation (LLLI) promotes proliferation of mesenchymal and cardiac stem cells in culture. Lasers Surg Med 2007, 39:373-378.
45. Tuby H., Maltz L., Oron U. Implantation of low-level laser irradiated mesenchymal stem cells into the infarcted rat heart is associated with reduction in infarct size and enhanced angiogenesis. Photomed Laser Surg 2009, 27:227-233.
46. Tuby H., Maltz L., Oron U. Induction of autologous mesenchymal stem cells in the bone marrow by low-level laser therapy has profound beneficial effects on the infarcted rat heart. Lasers Surg Med 2011, 43:401-409.
47. Uccelli A., Benvenuto F., Laroni A., Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 2011, 24:59-64.
48. Wallace B.A., Ashkan K., Heise C.E., Foote K.D., Torres N., Mitrofanis J., Benabid A.L. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 2007, 130:2129-2145.
49. Whelan H.T., Connelly J.F., Hodgson B.D., Barbeau L., Post A.C., Bullard G., Buchmann E.V., Kane M., Whelan N.T., Warwick A., Margolis D. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. J Clin Laser Med Surg 2002, 20:319-324.
50. Xuan W., Vatansever F., Huang L., Wu Q., Xuan Y., Dai T., Ando T., Xu T., Huang Y.Y., Hamblin M.R. Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. PLoS One 2013, 8:e53454.
51. Zivin J.A., Albers G.W., Bornstein N., Chippendale T., Dahlof B., Devlin T., Fisher M., Hacke W., Holt W., Ilic S., Kasner S., Lew R., Nash M., Perez J., Rymer M., Schellinger P., Schneider D., Schwab S., Veltkamp R., Walker M., Streeter J. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke 2009, 40:1359-1364.